HEALIUS LIMITED — Director's Dealing 2017

Mar 1, 2017

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	PRIMARY HEALTH CARE LIMITED
ABN	24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Mr Robert Hubbard
Date of last notice	23 February2015

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances givingrise to therelevantinterest.	As shown
Date of change	1 March 2017
No. of securities held prior tochange	11,000 Ordinary sharesParis SMSF ATF RobertHubbard & Leanne Muller
Class	Fully paid ordinary shares
Number acquired	10,000
Number disposed	Not applicable
Value/ConsiderationNote: If consideration is non-cash, provide detailsand estimated valuation	$3.315 per share
No. of securities held afterchange	21,000 Ordinary sharesParis SMSF ATF RobertHubbard & Leanne Muller
Nature of changeExample:on-markettrade,off-markettrade,exercise of options, issue of securities underdividend reinvestment plan, participation in buy-back	On-market trade

Part 2 – Change of director’s interests in contracts Not applicable

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contractsdetailed above traded during a+closed period whereprior written clearance was required?	Not applicable
If so, was prior written clearance provided to allow thetrade to proceed during this period?	Not applicable
If prior written clearance was provided, on what datewas this provided?	Not applicable

Charles Tilley Company Secretary Date: 2 March 2017

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011